This session addresses the use of mineralocorticoid receptor antagonists (MRAs) in the treatment of CKD. Discussion focuses on the pharmacokinetics of MRAs, indications for use in patients with CKD, potential adverse effects on the kidneys, and how to manage those effects.
Contact hours available until 9/25/19.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Conferences Committee Disclosures:
- Elizabeth St. John – Employee, Fresenius Kidney Care
- Marijo Johnson - Employee, Fresenius Medical Care
Speakers Conflict of Interest Disclosure: There are no other disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Nephrology nurses will state an increased ability to assess appropriately for the desired effects and the known side effects of mineralocorticoid receptor antagonists when used in patients with CKD.